AROA in the News

More from AROA

10 August 2021
Real-World Data shows Aroa Biosurgery’s Endoform™ Natural achieves significantly improved wound closure for Diabetic Foot Ulcers compared to traditional collagen dressings

Highlights A retrospective analysis of real-world data published in the ‘International Wound Journal’ compared the wound closure times for diabetic…

Read More
04 August 2021
Aroa Biosurgery’s Myriad Matrix receives validation for reconstruction of tissues affected by Pilonidal Sinus Disease

Highlights• AROA’s Myriad Matrix™ is further validated in a clinical study and peer-reviewed publication in Journal of Wound Care.• Study…

Read More
16 July 2021
Aroa Biosurgery June 2021 4C – Commentary

HIGHLIGHTS US medical procedure numbers continue to reflect a positive trend supporting improved sales momentum. AROA maintains its published product…

Read More
21 June 2021
Aroa Biosurgery releases FY2021 Annual Report

Aroa Biosurgery is pleased to release its first Annual Report since successfully completing its IPO and Admission onto the ASX…

Read More
28 April 2021
Aroa Biosurgery March 2021 4C – Commentary

HIGHLIGHTS H2 FY21 product revenues (unaudited) grew 16% on H2FY20 to $13.8m on a constant currency basis (i.e. eliminating impact…

Read More
06 April 2021
Aroa Biosurgery secures FDA clearance for new product, Myriad Morcells™, offering highly conformable tissue regeneration in wound beds

HIGHLIGHTS U.S. FDA 510(k) clearance received for a new Aroa Biosurgery product named Myriad Morcells™, a morcellized (powder) format of…

Read More
16 February 2021
Pilot study indicated benefits of Aroa Biosurgery’s Myriad™ in surgical reconstruction of chronic wounds

HIGHLIGHTS Aroa’s Myriad™ may be used successfully under a tissue flap to reduce surgical complications in the flap reconstruction of…

Read More
02 February 2021
Aroa Biosurgery to further expand fully dedicated sales team for key U.S. market

HIGHLIGHTS Aroa to expand on its own direct field sales presence in the United States market in a move expected…

Read More
16 December 2020
New study shows Aroa Biosurgery’s Myriad™ efficacy in healing exposed vital body structures

HIGHLIGHTS Aroa’s Myriad™ is further validated in a clinical study and peer-reviewed publication – Journal of Wound Care.Study shows 100%…

Read More
Developed by New Zealand Website Design